Curology, Inc.
DTC prescription skincare subscription now pushing into Walmart, CVS, and Target shelves.
On the record
Checkpoint: Walmart Rx Acne Kit pilot expansion decision beyond 1,000 stores
The call
Curology still holds the prescribing license and patient data that pure AI tools lack, but its core subscription business has shrunk sharply while it bets on retail shelves it doesn't own.
Curology lets people get acne prescriptions from licensed doctors through an app and subscription service, which is harder for pure AI apps to copy because of FDA rules. But other companies like Ro and Nurx do the same thing, and big drugmakers like Galderma can sell acne treatments in stores without needing the subscription model, so Curology's advantage isn't unique. The company has cut jobs by more than half and its online sales dropped more than 50% in one year, and now it is trying to sell products in Walmart and CVS stores alongside cheap store brands it can't beat. The one thing that could matter is whether Curology uses its collection of 5 million patient photos to build an AI tool that doctors and consumers actually want, instead of letting that data sit unused.
Why
01
AI pressure: Multimodal AI skin-analysis apps (photo-based acne/pigmentation triage). Apps now read skin conditions from a photo at GP-level accuracy, threatening the diagnosis step Curology built its funnel on. Could AI do the core job? Only partly.
02
Bigger players: Galderma. Galderma hired Curology's former CEO and controls regulated dermatology pharma distribution that Curology depends on for prescribing. Could a giant copy it? Probably.
03
What protects it. Licensed prescriber network plus 5M+ patient photo and history archive that AI apps and retailers cannot legally prescribe against.
What would change this call
Walmart Rx Acne Kit pilot expands past 1,000 stores toward 3,000+ after August 2026. Shows whether the retail pivot has repeatable economics or is stalling.
Curology headcount or DTC GMV figures reported again in 2027 filings or press. Shows whether the ~60% staff cuts and 50%+ GMV decline have stabilized or worsened.
Ro, Musely, or Nurx announce their own retail-shelf Rx-kit partnerships with a big-box chain. Shows peers replicating Curology's one retail differentiator, eroding any first-mover edge.
Curology headcount or DTC GMV figures reported again in 2027 filings or press. Shows whether the ~60% staff cuts and 50%+ GMV decline have stabilized or worsened.
Ro, Musely, or Nurx announce their own retail-shelf Rx-kit partnerships with a big-box chain. Shows peers replicating Curology's one retail differentiator, eroding any first-mover edge.
Key numbers
- DTC online GMV $23.5M in 2025, down over 50% YoY
- Headcount fell from 550 (2023) to roughly 200 (2026)
- Secondary shares $0.89 to $1.74, down from $1.15B 2021 valuation
Named risks
- Headcount contracted about 60% from 500+ peak to roughly 200 employees by April 2026.
- DTC GMV fell over 50% YoY to $23.5M in 2025.
- Valuation markdown from $1.15B (Feb 2021) to secondary quotes of $0.89-$1.74 per share by mid-2026.
- AI-powered skin-analysis apps validated at GP-level accuracy threaten top-of-funnel diagnosis and OTC recommendation as of April 2026.
- Current CEO identity unconfirmed by primary company statement as of mid-2026, signaling leadership instability.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Galderma | losing to | Pharma incumbent hired Curology's former CEO Heather Wallace to lead its US business before mid-2026 move |
| Apostrophe | gaining on | Direct Rx skincare rival reportedly ceased operating as of May 2026, opening share for Curology |
| Musely | contesting | Broader condition catalog (melasma, rosacea, hair thinning) vs Curology's acne/anti-aging focus, per 2025 comparison |
| Walmart and CVS private label acne products | losing to | Curology's retail pivot into Walmart (2024-08) and CVS (2024-07) puts it against shelf-commodity private label with no pricing edge |
| Ro (Rory brand) | contesting | Telehealth conglomerate's skincare vertical positioned as direct peer subscription teledermatology brand as of 2024-09 |
Questions people ask
- Is Curology profitable in 2026?
- No clear evidence of profitability in 2026. Curology's own curology.com online-store GMV fell to $23.5M in 2025, down over 50% year-over-year, while headcount shrank from 500+ peak to roughly 200-223 employees by April 2026, signaling contraction rather than profitable growth.
- Has Curology had layoffs?
- Yes. Curology laid off 147 employees in March 2022, and a 2024 Glassdoor review references three separate layoff rounds within a year. Headcount fell from roughly 500+ in 2021-22 to an estimated 200-223 employees by April 2026, a decline of about 60%.
- Who is Curology's biggest competitor?
- Curology competes directly with Musely, Ro's Rory skincare line, and Nurx in Rx teledermatology, while facing pharma incumbent Galderma (which hired Curology's former CEO Heather Wallace) and retail private-label acne products at Walmart and CVS as of 2026.
- Could AI replace Curology?
- AI threatens Curology's photo-based diagnosis and formula-suggestion funnel; 2026 research validated multimodal AI dermatology assistants at GP-level accuracy for acne and pigmentation from a single photo. However, Curology's licensed-provider prescribing and compounding-pharmacy supply chain remain regulatory barriers AI apps cannot fully replace.
- Who owns Curology?
- Curology is privately held and venture-backed, with no IPO filed as of 2026. Its last disclosed priced round was a $25M Series D-1 in February 2021 at a $1.15B post-money valuation, backed by investors including IVP, Forerunner Ventures, and Anthos Capital.
- Is Curology's valuation falling?
- Yes. Curology hit a $1.15B valuation in its February 2021 Series D-1 round, but private secondary-market trackers estimated share prices of just $0.89 to $1.74 as of mid-2026, an implied markdown from its unicorn peak, though this reflects modeled estimates, not a priced round.
Timeline
- 2026-07-22Former Curology CEO Heather Wallace named CEO of Future Beauty Brands after stint at Galderma
- 2026-07-16Curology and Walmart launch exclusive Prescription Acne Kit in 1,000 Walmart stores
- 2025-09Curology launches DayPrimeRx, a prescription acne treatment and makeup primer hybrid
- 2024-09Curology marks 10-year anniversary with Funfetti lip balm collaboration, claims 380% YoY retail distribution growth
- 2024-08Curology expands into roughly 3,338 Walmart stores nationwide
- 2024-07Curology expands into about 3,800 CVS stores; sister brand Agency launches on Amazon
- 2023-07Curology launches separate DTC storefront Curology Shop for non-Rx OTC products
- 2022-10Heather Wallace appointed CEO of Curology
- 2022-03Curology lays off 147 employees
- 2021-02Curology raises $25M Series D-1 at approximately $1.15B post-money valuation
Revision history
24 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- How Much Did Curology Raise? Funding & Key Investors (2025-04-07)
- Curology IPO Timeline and Financing Details (2023-11-14)
- How to Buy, Valuation, Stock Price, IPO (2026-07-15)
- Curology Appoints Heather Wallace as CEO (2022-10-10)
- Curology: From Telehealth Rocketship to Retail Reinvention (2025-11-19)
- curology.com eCommerce Revenue (2026-04-25)
- Curology and Walmart Join Forces (2026-07-16)
- Curology Revenue (2023-07-20)
- Revenue, Competitors, Alternatives (2022-04-16)
- Curology - 3 Massive Layoffs (2024-01-11)
- Curology Continues To Expand Retail Footprint... Walmart (2024-08-12)
- Curology Marks 10 Year Anniversary (2024-09-16)